Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:40 PM
Ignite Modification Date:
2025-12-24 @ 4:40 PM
NCT ID:
NCT03878966
Eligibility Criteria:
Inclusion Criteria:
* Patients from 18 to 85 years of both genders presented with NSTE-ACS with TIMI score ( ≥ 3), who will be subjected to early invasive strategy, whose coronary angiography shows de novo coronary artery disease (CAD) with a stenotic lesion ≥ 70 % requiring use of 2 stents or less.
Exclusion Criteria:
* • Patients with NSTEACS who will be subjected to conservative strategy.
* Patients whose coronary angiography shows CAD with significant lesions not candidate for PCI like target lesion location in the left main stem or multi vessel disease .
* In-stent restenosis .
* Stenosis in bypass graft .
* Raised renal chemistry (serum creatinine \> 2 mg/dl) .
* Known allergy to the contrast media or other medications used during and after percutaneous coronary intervention .
* Contraindication to antiplatelet (Asprin, Clopidogrel) or heparin therapy e.g. significant external or internal bleeding and active peptic ulcer .
* Severly impaired LV systolic function (LVEF \< 35%).
* Malignancies or other co-morbid conditions (for example, severe liver, renal, and pancreatic disease) with life expectancy\<6 months or that may result in protocol non-compliance .
* Pregnancy .
* Previous enrolment in this trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT03878966
Study Brief:
Protocol Section:
NCT03878966